Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

15 May 2013 07:00

RNS Number : 7174E
Alumasc Group PLC
15 May 2013
 



 FOR IMMEDIATE RELEASE 15 May 2013

 

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

 

Alumasc, the premium building and engineering products company, is publishing its final interim management statement for the year ending 30 June 2013, covering the period from 1 January 2013 to date.

 

Trading has continued to be satisfactory overall. Accordingly, the Board anticipates that results for the full year will be in line with its expectations.

 

The Building Products division has continued to outperform both a weak construction market and our own expectations, benefiting in particular from:

 

·; buoyant demand for Alumasc Insulated Renders and Gatic engineered access covers;

 

·; Levolux's large solar shading project at Chiswick Park, which is now almost complete; and

 

·; the £11million project to supply roofing and walling products to the aluminium smelter refurbishment at Kitimat in Canada. This project remains on track and is now over 50% complete.

 

The Engineering Products division experienced a difficult winter, with the lower demand from OEM customers signalled at the half-year stage impacting both Alumasc Precision Components (APC) and Dyson Diecastings (Dyson) in the third quarter of the financial year. Since then, there has been some modest recovery in activity levels. Steady progress continues to be made in the recovery plan at APC and Dyson remains strongly profitable.

 

The group's order books are healthy at £44 million, and cash flow performance also remains strong and in line with our expectations.

 

Paul Hooper, Chief Executive, commented: "It is pleasing to report that Alumasc continues to deliver a much improved trading performance, led by ongoing profitable growth in the Building Products division, and that the group is on course to achieve the Board's expectations for the full financial year".

 

ENDS

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield Tel: 0207 367 8888

Jasper Randall

 

This Interim Management Statement has been drawn up and presented for the purposes of complying with English laws and regulations. Any liability arising out of or in connection with this Interim Management Statement will also be determined in accordance with English law.

 

This Interim Management Statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors either beyond The Alumasc Group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

 

Nothing in this Interim Management Statement is intended to be a profit forecast.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQZLFFXEFLBBX
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.